BioCardia, Inc. (BCDA) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $541.00K; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $541.00K | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $541.00K |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 2.06M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | 541.00K USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current · Contract with Customer, Liability, Noncurrent · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Contract with Customer, Liability, Noncurrent · Deferred Revenue, Noncurrent · Contract with Customer, Liability, Current · Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | (m) | |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current · Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $293.00K |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $541.00K | (m) | (m) | (m) | $2.06M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $820.00K | (m) | (m) | (m) | $2.78M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $641.00K | (m) | (m) | (m) | $2.52M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.08M | (m) | (m) | (m) | $3.52M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $1.23M | (m) | (m) | (m) | $3.98M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $818.00K | (m) | (m) | (m) | $3.69M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $385.00K | (m) | (m) | (m) | $2.89M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $569.00K | (m) | (m) | (m) | $3.51M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $1.45M | (m) | (m) | (m) | $4.85M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $1.03M | (m) | (m) | (m) | $4.95M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $890.00K | (m) | (m) | (m) | $4.59M | (m) | $0.00 | (m) | (m) | (m) |
| 2023-09-30 | (m) | $507.00K | (m) | (m) | (m) | $4.41M | (m) | $0.00 | (m) | (m) | (m) |
| 2023-06-30 | (m) | $686.00K | (m) | (m) | (m) | $4.75M | (m) | $333.00K | (m) | (m) | (m) |
| 2023-03-31 | (m) | $861.00K | (m) | (m) | (m) | $5.23M | (m) | $340.00K | (m) | (m) | (m) |
| 2022-12-31 | (m) | $683.00K | (m) | (m) | (m) | $4.90M | (m) | $341.00K | (m) | (m) | (m) |
| 2022-09-30 | (m) | $887.00K | (m) | (m) | (m) | $5.08M | (m) | $378.00K | (m) | (m) | (m) |
| 2022-06-30 | (m) | $999.00K | (m) | (m) | (m) | $4.53M | (m) | $0.00 | (m) | (m) | (m) |
| 2022-03-31 | (m) | $764.00K | (m) | (m) | (m) | $5.47M | (m) | $948.00K | (m) | (m) | (m) |
| 2021-12-31 | (m) | $507.00K | (m) | (m) | (m) | $5.34M | (m) | $847.00K | (m) | (m) | (m) |
| 2021-09-30 | (m) | $846.00K | (m) | (m) | (m) | $3.92M | (m) | $886.00K | (m) | (m) | (m) |
| 2021-06-30 | (m) | $970.00K | (m) | (m) | (m) | $4.54M | (m) | $1.42M | (m) | (m) | (m) |
| 2021-03-31 | (m) | $850.00K | (m) | (m) | (m) | $4.75M | (m) | $1.18M | (m) | (m) | (m) |
| 2020-12-31 | (m) | $746.00K | (m) | (m) | (m) | $4.25M | (m) | $683.00K | (m) | (m) | (m) |
| 2020-09-30 | (m) | $1.21M | $773.00K | (m) | (m) | $5.39M | (m) | $90.00K | $683.00K | (m) | $0.00 |
| 2020-06-30 | (m) | $1.52M | $793.00K | (m) | (m) | $5.84M | (m) | $104.00K | $689.00K | (m) | $0.00 |
| 2020-03-31 | (m) | $1.11M | $793.00K | (m) | (m) | $5.67M | (m) | $104.00K | $689.00K | (m) | $0.00 |
| 2019-12-31 | (m) | $914.00K | $793.00K | (m) | (m) | $5.31M | (m) | $102.00K | $691.00K | (m) | $0.00 |
| 2019-09-30 | (m) | $1.11M | $943.00K | (m) | (m) | $5.49M | (m) | $252.00K | $691.00K | (m) | $0.00 |
| 2019-06-30 | (m) | $1.63M | (m) | (m) | (m) | $4.95M | (m) | $104.00K | (m) | (m) | (m) |
| 2019-03-31 | (m) | $1.14M | (m) | (m) | (m) | $4.34M | (m) | $118.00K | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.02M | (m) | (m) | (m) | $2.63M | (m) | $112.00K | (m) | (m) | (m) |
| 2018-09-30 | (m) | $1.10M | (m) | (m) | (m) | $2.61M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $505.00K | (m) | (m) | (m) | $1.90M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $738.00K | (m) | (m) | (m) | $2.20M | (m) | $60.00K | (m) | (m) | (m) |
| 2017-12-31 | (m) | $902.00K | (m) | (m) | (m) | $2.41M | (m) | $167.00K | (m) | (m) | (m) |
| 2017-09-30 | (m) | $447.00K | (m) | (m) | (m) | $2.08M | (m) | $160.00K | (m) | (m) | (m) |
| 2017-06-30 | (m) | $590.00K | (m) | (m) | (m) | $1.68M | (m) | $153.00K | (m) | (m) | (m) |
| 2017-03-31 | (m) | $291.00K | (m) | (m) | (m) | $1.43M | (m) | $72.00K | (m) | (m) | (m) |
| 2016-12-31 | (m) | $525.00K | (m) | (m) | (m) | $1.50M | (m) | $71.00K | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | $330.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | $10.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | $4.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $1.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | $5.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | $1.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | $1.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | $18.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | $10.00K | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $0.00 | (m) | (m) | (m) | $12.00K | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | $141.00K | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | $142.00K | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | $711.00K | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | $756.00K | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | $744.00K | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | $270.00K | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | $2.16M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |